Page last updated: 2024-11-04
sobuzoxane and ATLL
sobuzoxane has been researched along with ATLL in 4 studies
sobuzoxane: used in treatment of leukemia L1210
Research Excerpts
Excerpt | Relevance | Reference |
---|---|---|
"Among 13 acute-type ATLL, one CR and five PR were obtained." | 2.67 | Treatment of adult T-cell leukemia/lymphoma with MST-16, a new oral antitumor drug and a derivative of bis(2,6-dioxopiperazine). The MST-16 Study Group. ( Hanada, S; Hirano, M; Masaoka, T; Mitomo, Y; Nagai, K; Ohno, R; Sakamoto, S; Shirakawa, S; Yasunaga, K; Yokomaku, S, 1993) |
"Adult T cell leukemia/lymphoma (ATLL) induced by human T cell leukemia virus I is resistant to conventional therapy." | 2.67 | Effective treatment of adult T cell leukemia/lymphoma with a novel oral antitumor agent, MST-16. ( Fukutani, H; Ichihashi, T; Kiyoi, H; Kubo, K; Naoe, T; Ohno, R; Yamada, K; Yamauchi, T, 1992) |
"Sobuzoxane has an effect to protect against doxorubicin cardiotoxicity." | 2.40 | [Oral antitumor drugs for hematological malignancies]. ( Ohnishi, K, 1999) |
"The reason why CHOP-resistant ATLL responded dramatically to SBZ alone is not clear, but the plasma concentration of the metabolite of SBZ was possibly very high because of renal failure." | 1.36 | [Adult T-cell leukemia/lymphoma in a patient on hemodialysis-resistance to CHOP, but unexpected effect and remission achieved by sobuzoxane alone]. ( Murotani, N; Sakai, C, 2010) |
Research
Studies (4)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (75.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Sakai, C | 1 |
Murotani, N | 1 |
Ohno, R | 2 |
Masaoka, T | 1 |
Shirakawa, S | 1 |
Sakamoto, S | 1 |
Hirano, M | 1 |
Hanada, S | 1 |
Yasunaga, K | 1 |
Yokomaku, S | 1 |
Mitomo, Y | 1 |
Nagai, K | 1 |
Ohnishi, K | 1 |
Ichihashi, T | 1 |
Kiyoi, H | 1 |
Fukutani, H | 1 |
Kubo, K | 1 |
Yamauchi, T | 1 |
Naoe, T | 1 |
Yamada, K | 1 |
Reviews
1 review available for sobuzoxane and ATLL
Article | Year |
---|---|
[Oral antitumor drugs for hematological malignancies].
Topics: Administration, Oral; Antineoplastic Agents; Cytarabine; Etoposide; Hematologic Neoplasms; Humans; H | 1999 |
Trials
2 trials available for sobuzoxane and ATLL
Article | Year |
---|---|
Treatment of adult T-cell leukemia/lymphoma with MST-16, a new oral antitumor drug and a derivative of bis(2,6-dioxopiperazine). The MST-16 Study Group.
Topics: Administration, Oral; Adult; Aged; Animals; Antineoplastic Agents; Cats; Female; Humans; Leukemia-Ly | 1993 |
Effective treatment of adult T cell leukemia/lymphoma with a novel oral antitumor agent, MST-16.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Drug Evaluation; Female; Humans; Leukemia- | 1992 |
Other Studies
1 other study available for sobuzoxane and ATLL
Article | Year |
---|---|
[Adult T-cell leukemia/lymphoma in a patient on hemodialysis-resistance to CHOP, but unexpected effect and remission achieved by sobuzoxane alone].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Resistance | 2010 |